WallStreetZenWallStreetZen

NASDAQ: CURX
Curanex Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Curanex Pharmaceuticals revenue was N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CURX annual revenue was $0.0, with N/A growth year-over-year.

CURX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when CURX announces revenue.

CURX Revenue History By Year

CURX Yearly RevenueCURX RevenueCURX ChangeCURX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00-$26.00k-100.00%
2022-12-31$26.00kN/AN/A

1 of 1

Curanex Pharmaceuticals Revenue FAQ

What was CURX's revenue last quarter?

Curanex Pharmaceuticals (NASDAQ: CURX) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Curanex Pharmaceuticals's revenue was $0.00.

What was Curanex Pharmaceuticals's revenue in 2024?

Curanex Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Curanex Pharmaceuticals make in a day?

Based on Curanex Pharmaceuticals annual revenue for the past two years, CURX makes an average of $0.00 per day.

What was Curanex Pharmaceuticals's annual revenue growth in the past year?

As of Q3 2025, Curanex Pharmaceuticals's revenue has grown null year over year. Curanex Pharmaceuticals's revenue in the past year totaled N/A.

How much does Curanex Pharmaceuticals make in a year?

Curanex Pharmaceuticals's revenue by year for the past two years is:
  • Curanex Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Curanex Pharmaceuticals's annual revenue for Dec 31, 2023 was $0.00, a 100% decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.